Reengineering Methadone Treatment: A Randomized Clinical Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 300
- Locations
- 4
- Primary Endpoint
- Number of Participants With Opiate Positive Urine Tests
Study Overview
Brief Summary
The purpose of the study is to determine whether a change in the rules and staff roles in methadone treatment programs will result in greater lengths of stay in treatment and lower rates of heroin and cocaine use, crime and HIV-risk behavior as compared to methadone treatment as usual.
Detailed Description
Early drop-out and premature discharge from methadone treatment is common in the United States and may be associated with drug use and its associated problems. The purpose of this study is to evaluate the effectiveness of a novel approach to the organization methadone treatment in which the patient rules and staff roles of the clinic will be modified for study participants as compared to patients receiving standard methadone treatment.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •opiate dependence
- •newly admitted to methadone treatment
Exclusion Criteria
- •pregnancy
Arms & Interventions
Patient-Centered Methadone Treatment
Patient-Centered Methadone Treatment alters the rules and staff roles in methadone treatment as usual in an attempt to increase treatment retention and improve patient outcomes.
Intervention: Patient-Centered Methadone Treatment (Other)
Methadone Treatment as Usual
Methadone treatment provided as usual in the U.S.
Intervention: Methadone Treatment as usual (Other)
Outcomes
Primary Outcomes
Number of Participants With Opiate Positive Urine Tests
Time Frame: 12-months post-baseline
Number of participants with opiate positive urine tests
Secondary Outcomes
- Number of Participants With Cocaine Positive Urine Tests(12-months post-baseline)
- Drug Use HIV Risk Behavior(12-months post-baseline)
- Criminal Behavior(12-months post-baseline)
- Global Score on the World Health Organization Quality of Life Measure(12-months post-baseline)
- Number of Participants Meeting DSM-IV Opiate Dependence Criteria(12-months post-baseline)
- Number of Participants Meeting DSM-IV Cocaine Dependence Criteria(12-months post-baseline)